| Scrip Code | 533179 |
|---|---|
| NSE Symbol | PERSISTENT |
| MSEI Symbol | NOTLISTED |
| ISIN | INE262H01021 |
| Name of company | Persistent Systems Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 20-01-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 01-01-2026 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Third quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Audited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Audited |
| Segment Reporting | Multi segment |
| Description of single segment | |
| Start date and time of board meeting | 20-01-2026 08:30:00 |
| End date and time of board meeting | 20-01-2026 15:30:00 |
| Whether cash flow statement is applicable on company | |
| Type of cash flow statement | |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 3,77,820.50 | 10,69,251.20 | |
| Other income | 4,049.60 | 14,693.40 | |
| Total income | 3,81,870.10 | 10,83,944.60 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 0.00 | 0.00 |
| (b) | Purchases of stock-in-trade | 0.00 | 0.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 0.00 | 0.00 |
| (d) | Employee benefit expense | 2,60,059.10 | 7,38,988.90 |
| (e) | Finance costs | 1,896.40 | 5,400.70 |
| (f) | Depreciation, depletion and amortisation expense | 10,058.00 | 29,441.10 |
| (f) | Other Expenses | ||
| 1 | Purchase of software licenses | 24,972.90 | 69,499.80 |
| 2 | Legal and professional fees | 3,257.10 | 14,316.80 |
| 3 | Travelling and conveyance | 6,127.90 | 16,793.90 |
| 4 | Miscellaneous expenses | 1,918.70 | 5,377.50 |
| 5 | Recruitment expenses | 932.50 | 2,363.30 |
| 6 | Advertisement, conference and sponsorship fees | 666.60 | 1,483.50 |
| 7 | Rent | 322.80 | 816.60 |
| 8 | Allowance for expected credit loss (net) | 1,568.90 | 2,592.00 |
| 9 | Training and seminars | 530.70 | 1,311.20 |
| 10 | Other Expenses | 4,156.80 | 12,933.70 |
| Total other expenses | 44,454.90 | 1,27,488.30 | |
| Total expenses | 3,16,468.40 | 9,01,319.00 | |
| 3 | Total profit before exceptional items and tax | 65,401.70 | 1,82,625.60 |
| 4 | Exceptional items | (8,902.50) | (8,902.50) |
| 5 | Total profit before tax | 56,499.20 | 1,73,723.10 |
| 6 | Tax expense | ||
| 7 | Current tax | 14,040.60 | 44,605.20 |
| 8 | Deferred tax | (1,486.80) | (4,468.10) |
| 9 | Total tax expenses | 12,553.80 | 40,137.10 |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 43,945.40 | 1,33,586.00 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 43,945.40 | 1,33,586.00 |
| 17 | Other comprehensive income net of taxes | 1,258.90 | 3,999.30 |
| 18 | Total Comprehensive Income for the period | 45,204.30 | 1,37,585.30 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 43,945.40 | 1,33,586.00 | |
| Total profit or loss, attributable to non-controlling interests | 0.00 | 0.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 45,204.30 | 1,37,585.30 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 0.00 | 0.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 7,887.50 | 7,887.50 | |
| Face value of equity share capital | 5 | 5 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 28.15 | 85.89 | |
| Diluted earnings (loss) per share from continuing operations | 27.94 | 85.29 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 28.15 | 85.89 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 27.94 | 85.29 | |
| 24 | Debt equity ratio | 0 | 0 |
| 25 | Debt service coverage ratio | 0 | 0 |
| 26 | Interest service coverage ratio | 0 | 0 |
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | Due to character limitation in filling the notes in this tab, please refer to our submission under Ref. No. NSE & BSE / 2025-26 / 193 dated January 20, 2026, which covers the consolidated financial results under Regulation 33 of the SEBI (LODR) Regulations, 2015, including notes thereto. |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-10-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 31-12-2025 | 31-12-2025 | |||||
| Whether results are audited or unaudited | Audited | Audited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| 1 | Banking, Financial Services and Insurance (BFSI) | 1,32,131.70 | 3,69,702.10 | ||||
| 2 | Healthcare & Life Sciences | 96,046.70 | 2,70,588.90 | ||||
| 3 | Software, Hi-Tech and Emerging Industries | 1,49,642.10 | 4,28,960.20 | ||||
| Total Segment Revenue | 3,77,820.50 | 10,69,251.20 | |||||
| Less: Inter segment revenue | 0.00 | 0.00 | |||||
| Revenue from operations | 3,77,820.50 | 10,69,251.20 | |||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| 1 | Banking, Financial Services and Insurance (BFSI) | 44,833.70 | 1,27,168.50 | ||||
| 2 | Healthcare & Life Sciences | 35,321.20 | 1,00,337.10 | ||||
| 3 | Software, Hi-Tech and Emerging Industries | 49,574.70 | 1,51,021.70 | ||||
| Total Profit before tax | 1,29,729.60 | 3,78,527.30 | |||||
| i. Finance cost | 1,896.40 | 5,400.70 | |||||
| ii. Other Unallocable Expenditure net off Unallocable income | 71,334.00 | 1,99,403.50 | |||||
| Profit before tax | 56,499.20 | 1,73,723.10 | |||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| 1 | Banking, Financial Services and Insurance (BFSI) | 86,911.40 | 86,911.40 | ||||
| 2 | Healthcare & Life Sciences | 58,741.40 | 58,741.40 | ||||
| 3 | Software, Hi-Tech and Emerging Industries | 2,04,314.70 | 2,04,314.70 | ||||
| Total Segment Asset | 3,49,967.50 | 3,49,967.50 | |||||
| Un-allocable Assets | 7,40,707.20 | 7,40,707.20 | |||||
| Net Segment Asset | 10,90,674.70 | 10,90,674.70 | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| 1 | Banking, Financial Services and Insurance (BFSI) | 0.00 | 0.00 | ||||
| 2 | Healthcare & Life Sciences | 0.00 | 0.00 | ||||
| 3 | Software, Hi-Tech and Emerging Industries | 0.00 | 0.00 | ||||
| Total Segment Liabilities | 0.00 | 0.00 | |||||
| Un-allocable Liabilities | 3,13,919.10 | 3,13,919.10 | |||||
| Net Segment Liabilities | 3,13,919.10 | 3,13,919.10 | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-10-2025 | 01-04-2025 |
| B | Date of end of reporting period | 31-12-2025 | 31-12-2025 |
| C | Whether results are audited or unaudited | Audited | Audited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurements of the defined benefit liabilities / asset | (811.50) | 279.40 |
| Total Amount of items that will not be reclassified to profit and loss | (811.50) | 279.40 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | (189.20) | 70.30 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Effective portion of cash flow hedge (net of tax) | (725.10) | (8,401.00) |
| 2 | Exchange differences in translating the financial statements of foreign operations | 2,423.80 | 10,076.80 |
| Total Amount of items that will be reclassified to profit and loss | 1,698.70 | 1,675.80 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | (182.50) | (2,114.40) |
| 5 | Total Other comprehensive income | 1,258.90 | 3,999.30 |